AUS
NZ
UK
CA
USA
IND
Highlights
- Memphasys Limited (ASX:MEM) has AU$3.93m in debt and AU$516.3k cash.
- Net debt of AU$3.41m is manageable given its AU$14.2m market cap.
- The company faces challenges with liabilities surpassing cash and receivables by AU$3.28m.
Warren Buffett's insightful observation that "volatility is far from synonymous with risk" rings especially true when considering the role of debt in a company's financial structure. Among these considerations, Memphasys Limited (ASX:MEM) stands out, as it maintains a level of debt that shareholders should keep in mind.
When Does Debt Pose a Risk?
Debt often becomes a concern if a company struggles to comfortably fulfill its financial obligations, either through generating revenue or raising capital. If it fails, shareholders might face significant equity dilution or even lose their investments. However, companies sometimes manage debt to their advantage, enhancing shareholder value. Therefore, assessing Memphasys Limited's cash and debt levels becomes essential.
A Closer Look at Memphasys's Debt Situation
As of December 2024, Memphasys carried AU$3.93 million in debt, along with AU$516.3k in cash, resulting in net debt of approximately AU$3.41 million. Despite this, the company's market capitalization of AU$14.2 million indicates a potential to improve its balance sheet via capital raising if necessary. Nevertheless, vigilance is necessary to ensure that the debt level remains manageable without causing dilution.
Balance Sheet Health Check
Memphasys's liabilities due within a year stand at AU$4.60 million, with an additional AU$309.8k payable beyond that timeframe. These obligations outweigh the combined value of its cash and receivables, which total at AU$1.63 million, leaving a deficit of AU$3.28 million. Despite this, the company's market cap indicates potential flexibility to stabilize its finances if needed.
Given the lack of significant current operating revenue, the pace at which Memphasys can generate revenue is crucial to its financial health. Without immediate earnings improvement, the company's reliance on external funding might grow.
Proceed with Caution
In the past year, Memphasys has experienced an earnings before interest and tax (EBIT) loss of AU$3.6 million, and negative free cash flow of the same amount, signaling caution. Though their balance sheet has room for improvement, it is not beyond repair. As such, investors should remain aware of several warning signs and assess their risk tolerance accordingly.
